Literature DB >> 904692

Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog.

W A Buylaert.   

Abstract

On local injection into the innervated hindleg of the dog piribedil, like apomorphine, produced a vasodilatation blocked by haloperidol. S584, the catechol metabolite of piribedil, produced a vasodilatation which was not blocked by haloperidol. Neither propranolol nor atropine influenced the vasodilatation produced by piribedil or S584. Denervation of the hindleg abolished the responses to piribedil and S584. During the infusion of noradrenaline into the denervated hindleg, the responses to S584 reappeared but those to piribedil did not. It is concluded from these experiments that the vasodilatation produced by piribedil in the innervated hindleg of the dog, like that of apomorphine, is mediated by dopamine receptors and that the effect of piribedil cannot be explained by the formation of its catechol metabolite S584.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 904692     DOI: 10.1007/bf00508645

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.

Authors:  L L Iversen; A S Horn; R J Miller
Journal:  Adv Neurol       Date:  1975

2.  Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect.

Authors:  M Laubie; H Schmitt; E Falq
Journal:  Eur J Pharmacol       Date:  1977-04-07       Impact factor: 4.432

3.  Dopamine-induced inhibition of synaptic transmission in lumbar paravertebral ganglia of the dog.

Authors:  J L Willems
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

5.  Cardiovascular effects of the 1-(2" pyrimidyl)-5 piperonyl piperazine (ET 495).

Authors:  M Laubie; H Schmitt; J C Le Douarec
Journal:  Eur J Pharmacol       Date:  1969-05       Impact factor: 4.432

6.  Synthesis and vasodilator activity of new piperazine derivatives.

Authors:  G L Regnier; R J Canevari; M J Laubie; J C Le Douarec
Journal:  J Med Chem       Date:  1968-11       Impact factor: 7.446

7.  Vasodilatation produced by apomorphine in the hindleg of the dog.

Authors:  W A Buylaert; J L Willems; M G Bogaert
Journal:  J Pharmacol Exp Ther       Date:  1977-06       Impact factor: 4.030

8.  Drug interactions with dopamin-stimulated adenylate cyclasses of caudate nucleus and retina: direct agonist effect of a piribedil metabolite.

Authors:  M H Makman; R K Mishra; J H Brown
Journal:  Adv Neurol       Date:  1975
  8 in total
  1 in total

1.  Prejunctional actions of piribedil on the isolated kidney of the rabbit: comparison with apomorphine.

Authors:  C Chevillard; M N Mathieu; D Recommis
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.